Search results
Can CureVac N.V. (CVAC) Climb 191.74% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo News· 7 months agoThe mean of analysts' price targets for CureVac N.V. (CVAC) points to a 191.7% upside in the stock....
Pfizer, BioNTech seek to revoke CureVac's patent infringement claims
Reuters via Yahoo News· 2 years agoIn July, CureVac had filed a patent lawsuit against BioNTech over its use of mRNA technology,...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo News· 1 month agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Bet on These 4 Biotech Stocks With Bright Prospects
Zacks via Yahoo News· 2 years agoNew drug approvals and pipeline development should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and pipeline...
Company News for Jan 11, 2023
Zacks via Yahoo News· 1 year agoShares of TD SYNNEX Corp. SNX surged 4.7% after reporting fourth quarter fiscal 2022 adjusted earnings per share of $3.44, surpassing the Zacks Consensus...
